Clinical assays for vaccine development: the role of CEPI centralized laboratory network

Vaccine Insights 2024; 3(4), 113–117

DOI: 10.18609/vac.2024.021

Published: 25 June
Ali Azizi

Established to offer free sample testing for vaccine developers during the COVID-19 pandemic, CEPI’s centralized laboratory network has continued to expand and is now addressing a range of pandemic threats. Charlotte Barker, Commissioning Editor, Vaccine Insights, speaks with Ali Azizi, Project Lead, CEPI, to find out more.